Almirall S.A. | Mutual Funds

Mutual Funds that own Almirall S.A.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Government Pension Fund - Global (The)
2,447,817
1.41%
-1,218,028
0.01%
12/31/2017
Generali Investments SICAV - European Recovery Equity Fund
1,600,000
0.92%
0
6.13%
12/29/2017
Santander Small Caps España, FI
1,437,042
0.83%
842,544
2.56%
12/31/2017
Santander Acciones Españolas, FI
1,301,797
0.75%
-235,140
1.64%
03/31/2018
Sabadell España Dividendo, FI
925,339
0.53%
223,663
6.9%
03/31/2018
Mutuafondo España, FI
907,314
0.52%
173,981
8.36%
12/31/2017
BBVA Bolsa, FI
895,707
0.52%
895,707
7.6%
02/28/2018
Vanguard Total International Stock Index Fund
850,559
0.49%
0
0%
07/31/2018
844,318
0.49%
71,001
6.02%
03/31/2018
Fidelity Funds SICAV - Iberia Fund
816,386
0.47%
-45,350
1.99%
05/31/2018

About Almirall

View Profile
Address
Ronda General Mitre, 151
Barcelona Catalonia 08022
Spain
Employees -
Website http://www.almirall.com
Updated 07/08/2019
Almirall SA engages in the development, manufacture, storage, commercialization and sale of pharmaceutical and cosmetic products, as well as of the raw materials used in production. The company operates through the following segments: Marketing through Own Network, Marketing by Licensees, Research and Development Activity, Therapeutic Area of Dermatology in the United States, and Corporate Management and Results not assigned to Other Segments. Its products include treatments for respiratory, autoimmune, dermatological and gastrointestinal diseases.